IL158147A0 - Methods and cells for identifying cancer-related genes - Google Patents

Methods and cells for identifying cancer-related genes

Info

Publication number
IL158147A0
IL158147A0 IL15814702A IL15814702A IL158147A0 IL 158147 A0 IL158147 A0 IL 158147A0 IL 15814702 A IL15814702 A IL 15814702A IL 15814702 A IL15814702 A IL 15814702A IL 158147 A0 IL158147 A0 IL 158147A0
Authority
IL
Israel
Prior art keywords
methods
cells
related genes
identifying cancer
cancer
Prior art date
Application number
IL15814702A
Other languages
English (en)
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of IL158147A0 publication Critical patent/IL158147A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276Knock-out vertebrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/20Animal model comprising regulated expression system
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0331Animal model for proliferative diseases
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0393Animal model comprising a reporter system for screening tests
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/30Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15814702A 2001-03-28 2002-03-28 Methods and cells for identifying cancer-related genes IL158147A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27950601P 2001-03-28 2001-03-28
PCT/US2002/009710 WO2002079419A2 (en) 2001-03-28 2002-03-28 Identifying and characterizing genes

Publications (1)

Publication Number Publication Date
IL158147A0 true IL158147A0 (en) 2004-03-28

Family

ID=23069287

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15814702A IL158147A0 (en) 2001-03-28 2002-03-28 Methods and cells for identifying cancer-related genes
IL158147A IL158147A (en) 2001-03-28 2003-09-26 Methods and cells for identifying cancer-related genes

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158147A IL158147A (en) 2001-03-28 2003-09-26 Methods and cells for identifying cancer-related genes

Country Status (11)

Country Link
US (1) US7371515B2 (da)
EP (1) EP1450602B1 (da)
JP (2) JP4170766B2 (da)
AT (1) ATE406094T1 (da)
CA (1) CA2442349C (da)
DE (1) DE60228609D1 (da)
DK (1) DK1450602T3 (da)
ES (1) ES2312607T3 (da)
IL (2) IL158147A0 (da)
NZ (1) NZ529101A (da)
WO (1) WO2002079419A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004077942A2 (en) * 2003-02-28 2004-09-16 Genpath Pharmaceuticals, Incorporated Inducible prostate cancer model
WO2004089073A2 (en) * 2003-04-03 2004-10-21 Genpath Pharmaceuticals, Incorporated Inducible breast cancer model
CA2523517C (en) 2003-04-25 2013-07-30 Dana-Farber Cancer Institute, Inc. Bcl2l12 polypeptide activators and inhibitors
JP4733644B2 (ja) * 2003-11-26 2011-07-27 ダナ−ファーバー キャンサー インスティテュート インク. 膵臓腺癌の動物モデルおよびその使用
US9345788B2 (en) 2004-12-07 2016-05-24 Aveo Pharmaceuticals, Inc. Reconstituted human breast tumor model
US20060198789A1 (en) * 2005-01-06 2006-09-07 Zhigang Weng Target validation assay
US20060222590A1 (en) 2005-04-05 2006-10-05 Murray Robinson Directed complementation
JP2007306885A (ja) * 2006-05-22 2007-11-29 Mitsubishi Chemicals Corp 新規非ヒト動物
JP2010529834A (ja) * 2007-05-21 2010-09-02 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド 癌遺伝子の発見のための組成物および方法
US8731956B2 (en) * 2008-03-21 2014-05-20 Signature Genomic Laboratories Web-based genetics analysis
US8954337B2 (en) * 2008-11-10 2015-02-10 Signature Genomic Interactive genome browser
AU2015225867B2 (en) * 2014-03-07 2020-02-06 University Health Network Methods and compositions for modifying the immune response
CN108368479A (zh) * 2015-09-29 2018-08-03 细胞结构公司 细胞效能分析
US10424397B2 (en) * 2015-12-18 2019-09-24 International Business Machines Corporation Classification and identification of disease genes using biased feature correction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919997A (en) * 1993-11-18 1999-07-06 Cold Spring Habor Labortary Transgenic mice having modified cell-cycle regulation
US5965440A (en) * 1995-12-07 1999-10-12 The General Hospital Corporation Controlled gene product delivery from a regulatable retroviral vector
AU751520B2 (en) * 1998-03-27 2002-08-15 Lexicon Pharmaceuticals, Inc. Vectors for gene mutagenesis and gene discovery
US6639121B1 (en) 1999-07-29 2003-10-28 Dana-Farber Cancer Institute, Inc. Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo

Also Published As

Publication number Publication date
WO2002079419A3 (en) 2004-06-17
WO2002079419A2 (en) 2002-10-10
JP2004535786A (ja) 2004-12-02
IL158147A (en) 2008-07-08
EP1450602A2 (en) 2004-09-01
DK1450602T3 (da) 2008-11-24
ES2312607T3 (es) 2009-03-01
JP2008263987A (ja) 2008-11-06
ATE406094T1 (de) 2008-09-15
EP1450602B1 (en) 2008-08-27
NZ529101A (en) 2008-04-30
DE60228609D1 (de) 2008-10-09
US7371515B2 (en) 2008-05-13
US20030003478A1 (en) 2003-01-02
CA2442349A1 (en) 2002-10-10
CA2442349C (en) 2011-10-25
EP1450602A4 (en) 2005-03-16
JP4170766B2 (ja) 2008-10-22

Similar Documents

Publication Publication Date Title
IL158147A0 (en) Methods and cells for identifying cancer-related genes
WO2005047524A3 (en) Compositions and methods for inducing cell dedifferentiation
WO2006108183A3 (en) Label free biosensors and cells
PH12013501101B1 (en) Immunosuppressive polypeptides and nucleic acids
WO2002030465A3 (en) Compositions that inhibit proliferation of cancer cells
NL1021701A1 (nl) PEM-brandstofcel.
CY1111769T1 (el) Παρασκευη κυτταρων
MXPA03006226A (es) Sistema de enfriamiento de celda de combustible.
TNSN07157A1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
AU301839S (en) Pipe gland ear
WO2006010150A3 (en) Housekeeping genes and methods for identifying the same
NO20010843L (no) Subtile mitokondrie mutasjoner som tumor markörer
CA101715S (en) Multiple-bladed thicket knife
ZA200207704B (en) Multi-stage combustion for fuel processing for use with fuel cell.
GB0310880D0 (en) Resistance dilution
AU2002217721A8 (en) Viral vector for gene therapy
EP1563558A4 (en) ALCOHOL-AIR FUEL CELL
DK1230261T3 (da) NY-ESO-1 Nonapeptidderivater og anvendelser af disse
PL360642A1 (en) Method and set designed for detection of high genetic predisposition for prostate gland cancer as well as use of germinal change within the nbs1 gene
GB0229261D0 (en) Cells,culture methods and their uses
WO2005047475A3 (en) Regulation of cell membrane-mediated effects
WO2004075315A3 (en) Battery containing fibrous material
GB0419929D0 (en) Portable fuel cell system
WO2004089073A3 (en) Inducible breast cancer model
DE112004002487D2 (de) Brennstoffzellensystem

Legal Events

Date Code Title Description
KB Patent renewed